Partner Investment Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Partner Investment Management’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-10,098	Closed	-$760K	–	111
2015 Q2	$760K	Sell	10,098 -19,080	-65%	-$1.02M	1.07%	39
2015 Q1	$1.46M	Buy	29,178 +4,722	+19%	+$198K	2.2%	13
2014 Q4	$848K	Buy	24,456 +2,013	+9%	+$70.2K	0.35%	55
2014 Q3	$735K	Sell	22,443 -13,730	-38%	-$484K	0.27%	38
2014 Q2	$1.39M	Sell	36,173 -3,226	-8%	-$113K	0.28%	41
2014 Q1	$1.57M	Buy	39,399 +13,104	+50%	+$586K	0.29%	46
2013 Q4	$982K	Buy	26,295 +2,700	+11%	+$112K	0.22%	41
2013 Q3	$1.08M	Sell	23,595 -14,165	-38%	-$424K	0.29%	43
2013 Q2	$1.02M	Buy	+37,760	New	+$864K	0.23%	46

Other funds holding KYTH

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Partner Investment Management's KYTH Position: Q3 2015 in Review

Partner Investment Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2015, closing a stake of 10,098 shares — an estimated $760K sold.

Partner Investment Management first reported a position in KYTH in Q2 2013 and held it in 9 quarters. The position peaked at $1.57M in Q1 2014. 143 funds tracked by Wall St. Rank hold KYTH as of Q3 2015.

Partner Investment Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2015 after selling out during the quarter.
Partner Investment Management sold 10,098 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2015, an estimated $760K.
Partner Investment Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 9 quarters.
Partner Investment Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $1.57M in Q1 2014.
143 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2015.

Based on Partner Investment Management's 13F filing for Q3 2015, filed 16 Nov 2015.